Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

about

Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH.

P2860

Q47584564-86D14810-1208-4DB3-AEC5-AC651A424254

P2860

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

Item

http://www.wikidata.org/entity/Q47847406

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

@en

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

@nl

type

Item

label

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

@en

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

@nl

prefLabel

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

@en

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

@nl

P1476

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

@en

P2093

Dean Billheimer

http://www.w3.org/2001/XMLSchema#string

Joel E Lavine

http://www.w3.org/2001/XMLSchema#string

John D Clarke

http://www.w3.org/2001/XMLSchema#string

Mark J Canet

http://www.w3.org/2001/XMLSchema#string

Nathan J Cherrington

http://www.w3.org/2001/XMLSchema#string

Robert P Erickson

http://www.w3.org/2001/XMLSchema#string

Stavra A Xanthakos

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease

Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Synergistic interaction between genetics and disease on pravastatin disposition

Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes.

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.

Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease.

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

P304

1317-1325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.117.077644

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hui Li

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28986475

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

5697442

http://www.w3.org/2001/XMLSchema#string

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

about

P2860

P2860

Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932